Lanolimus 0.5mg Tablet

Overview

Lanolimus contains Everolimus, a medicine commonly prescribed to help manage certain cancers and to prevent organ rejection after a transplant. It works by slowing down the growth of abnormal cells and controlling the body’s immune response. This low-dose 0.5 mg strength is usually used when doctors need to adjust treatment gradually or when patients require smaller, divided doses.

How It Works

Everolimus belongs to a group of medicines called mTOR inhibitors.
It helps by:

• Reducing the activity of overactive cells
• Slowing the growth of tumors
• Helping maintain a stable immune system after organ transplant

Common Uses

• Your doctor may prescribe Everolimus for:
• Breast cancer, kidney cancer, or neuroendocrine tumors
• TSC-related tumors (such as renal angiomyolipoma)
• Preventing transplant rejection (kidney, liver)

Key Benefits

• Scientifically backed treatment for specific cancers
• Useful for dose adjustments in long-term therapy
• Manufactured by a globally trusted pharmaceutical company
• Safety & Precautions
• Take only on a doctor’s prescription
• Do not self-adjust or skip doses
• Regular blood tests are often required
• Notify your doctor if you notice fever, mouth ulcers, or unusual tiredness

Scientific Literature (External Links)

Here are reliable sources for customers who want to learn more:

Everolimus mechanism of action – National Center for Biotechnology Information (NCBI):
https://www.ncbi.nlm.nih.gov/books/NBK544241/

Everolimus in cancer treatment (clinical review) – PubMed:
https://pubmed.ncbi.nlm.nih.gov/23486238/

Use of Everolimus in transplant medicine – NCBI:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3497003/

These details are compiled from publicly available scientific sources. MYMEDS.MD is not liable for clinical interpretation. Please consult a licensed medical practitioner for personalised guidance.